Table 2. High levels of anti-GM-CSF... | American Society of Hematology

Table 2.

High levels of anti-GM-CSF autoantibodies in iPAP patients

Sample	iPAP median, μg/mL	Healthy control^*median, μg/mL	Other lung disorders^*median, μg/mL
BALF	1.15 (0.094-5.40), n = 34	< 0.050, n = 18	< 0.050, n = 14
Serum	88.6 (16.6-470), n = 107	< 3.00, n = 19	< 3.00, n = 10

Sample	iPAP median, μg/mL	Healthy control^*median, μg/mL	Other lung disorders^*median, μg/mL
BALF	1.15 (0.094-5.40), n = 34	< 0.050, n = 18	< 0.050, n = 14
Serum	88.6 (16.6-470), n = 107	< 3.00, n = 19	< 3.00, n = 10

Numbers in parentheses are ranges.

Concentrations of autoantibodies in BALF and serum were all under the detection limit (0.05 μg/mL in BALF; 3 μg/mL in serum).